Join our dedicated team

NEWS

ViroSpot MN assay, a novel tool for antigenic characterization of influenza viruses and serology.
The ViroSpot assay platform is currently available for influenza virus and RSV, and under development for multiple other viral targets.

Specialized team of scientists

NEWS

ViroSpot MN assay, a novel tool for antigenic characterization of influenza viruses and serology.
The ViroSpot assay platform is currently available for influenza virus and RSV, and under development for multiple other viral targets.

Virology Contract Research Laboratory

JOB OPPORTUNITIES

Viroclinics Biosciences is a leader in the strongly growing and very dynamic market of diagnostic services companies. As a service organization we offer serological, virus-based and molecular analyses of any type of sample to assist our global customers with testing their antiviral drugs and vaccines. Our analyses encompass many types of viruses, including Influenza, RSV and Polio. Our rapidly growing company is now expanding its HBV Business Unit. 

This expansion is part of our growth strategy and allows for hiring two new key leadership positions: a Director HBV Business Development and a Director HBV Services.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

OUR LATEST NEWS

Parcom Capital acquires Viroclinics Biosciences

Parcom Capital has acquired the successful clinical research organisation Viroclinics Biosciences. Viroclinics believes Parcom is the perfect partner to help it realise its growth ambitions.

↓